Nuclear Medicine

The institute of Nuclear Medicine works in cooperation with other departments to perform joint studies in a number of fields: cardiology, oncology, infertility etc.

Research Activities include:

A quantitative method of assessing the severity of testicular varicocele. A new radio-pharmaceutical for myocardial perfusion imaging, Tc-Tetrofosmin utilizing the Elscint SPECT gamma camera and computer software. First line treatment of women with metastatic breast cancer - cardiac scans (MUGA) before and after chemotherapy. Monoclonal antibody radioimmune therapy in patients with ovarian carcinoma. Evaluation of a new technique called Intravascular Bradytherapy. The efficacy of a nuclear probe device in breast cancer patients undergoing lymph node dissection. Ingestible radioactive capsule imaging device to diagnose small bowel disease. Mucociliary clearance in normal subjects and patients with Cystic Fibrosis utilizing radioactive labeled particles. Intravascular Brachytherapy System in improving the durability of dialysis graft revisions. The efficacy of a new drug in patients with acute myocardial infarction, using the MUGA scan for left ventricular function evaluation. A new radiopharmaceutical, Tc-sestamibi, for breast cancer detection. A new isotopic technique in sentinel node detection in melanoma and breast cancer. Evaluation of intra-coronary stent restenosis utilizing radionuclide myocardial perfusion imaging. Evaluation of effect of estrogen on myocardial ischemia in post-menopausal women.

Contact Info

Contact Person Dr. Daniel Hain, Director, Department of Nuclear Medicine
Address 4th floor, Shaare Zedek Medical Center
Phone 972-2-6555520